PT998930E - Composto azasteroide para o tratamento da alopecia hirsutismo ou seborreia - Google Patents

Composto azasteroide para o tratamento da alopecia hirsutismo ou seborreia

Info

Publication number
PT998930E
PT998930E PT98933945T PT98933945T PT998930E PT 998930 E PT998930 E PT 998930E PT 98933945 T PT98933945 T PT 98933945T PT 98933945 T PT98933945 T PT 98933945T PT 998930 E PT998930 E PT 998930E
Authority
PT
Portugal
Prior art keywords
alopecia
composition
seborria
hirsutismo
azasteroid
Prior art date
Application number
PT98933945T
Other languages
English (en)
Inventor
Koichi Kojima
Takakazu Hamada
Shiroh Yosioka
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of PT998930E publication Critical patent/PT998930E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
PT98933945T 1997-07-29 1998-07-27 Composto azasteroide para o tratamento da alopecia hirsutismo ou seborreia PT998930E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20313697 1997-07-29

Publications (1)

Publication Number Publication Date
PT998930E true PT998930E (pt) 2004-05-31

Family

ID=16469018

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98933945T PT998930E (pt) 1997-07-29 1998-07-27 Composto azasteroide para o tratamento da alopecia hirsutismo ou seborreia

Country Status (22)

Country Link
US (1) US6380179B1 (pt)
EP (1) EP0998930B1 (pt)
KR (1) KR20010022066A (pt)
CN (1) CN1129433C (pt)
AT (1) ATE262337T1 (pt)
AU (1) AU733830B2 (pt)
BR (1) BR9811293A (pt)
CA (1) CA2298851A1 (pt)
DE (1) DE69822636T2 (pt)
DK (1) DK0998930T3 (pt)
ES (1) ES2218840T3 (pt)
HK (1) HK1027290A1 (pt)
HU (1) HUP0003159A3 (pt)
ID (1) ID24566A (pt)
IL (1) IL134199A0 (pt)
NO (1) NO20000469L (pt)
NZ (1) NZ502537A (pt)
PL (1) PL338414A1 (pt)
PT (1) PT998930E (pt)
RU (1) RU2193887C2 (pt)
TR (1) TR200000263T2 (pt)
WO (1) WO1999006050A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL335365A1 (en) * 1997-02-26 2000-04-25 Sankyo Co Composition for treating or preventing prostatic carcinoma
WO2005074985A2 (en) * 2004-02-02 2005-08-18 Schering Corporation Methods of modulating cd200 and cd200r
US20080108681A1 (en) * 2006-10-27 2008-05-08 Access Business Group International Llc Use of allantoin as a pro-collagen synthesis agent in cosmetic compositions
CA2769512C (en) 2009-07-29 2019-07-09 Duke University Compositions comprising fp receptor antagonists and their use for inhibiting hair growth
MX2010012945A (es) * 2010-11-24 2012-05-24 Fidel Ojeda Gomez Una formula para el control y eliminacion de seborrea y alopecia en el cuero cabelludo.
RU2477155C2 (ru) * 2011-04-27 2013-03-10 Закрытое акционерное общество "Патент-Фарм" Способ лечения андрогенетической алопеции

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571817A (en) 1984-02-27 1996-11-05 Merck & Co., Inc. Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones]
US5516768A (en) 1990-03-16 1996-05-14 Smithkline Beecham Corporation Uncompetitive inhibition of steroid and 5α-reductose
IE76452B1 (en) * 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
JP3030152B2 (ja) * 1992-02-03 2000-04-10 三共株式会社 4−アザステロイド化合物
TW382595B (en) 1993-10-15 2000-02-21 Merck & Co Inc Pharmaceutical composition for use in arresting and reversing androgenic alopecia
JPH0873492A (ja) * 1994-06-28 1996-03-19 Sankyo Co Ltd アザステロイド類
US5635197A (en) 1995-03-21 1997-06-03 Eli Lilly And Company Treatment and prevention of prostatic cancer metastasis
US5629007A (en) 1995-03-21 1997-05-13 Eli Lilly And Company Method of preventing prostatic cancer development
WO1997011702A1 (en) 1995-09-27 1997-04-03 Merck & Co., Inc. Method of preventing androgenetic alopecia with 5-alpha reductase inhibitors
AU709146B2 (en) * 1996-02-05 1999-08-19 Sankyo Company Limited Formulation of 5alpha-reductase inhibitor for oral administration, and a preparation process and use thereof
US6093722A (en) 1997-02-26 2000-07-25 Sankyo Company, Limited Method for treating prostate cancer
PL335365A1 (en) * 1997-02-26 2000-04-25 Sankyo Co Composition for treating or preventing prostatic carcinoma

Also Published As

Publication number Publication date
KR20010022066A (ko) 2001-03-15
EP0998930B1 (en) 2004-03-24
CN1271285A (zh) 2000-10-25
HUP0003159A2 (hu) 2001-04-28
ES2218840T3 (es) 2004-11-16
HUP0003159A3 (en) 2001-07-30
AU8358598A (en) 1999-02-22
IL134199A0 (en) 2001-04-30
BR9811293A (pt) 2000-08-29
CN1129433C (zh) 2003-12-03
DK0998930T3 (da) 2004-04-26
AU733830B2 (en) 2001-05-24
NO20000469D0 (no) 2000-01-28
EP0998930A4 (en) 2002-06-12
DE69822636T2 (de) 2005-01-05
CA2298851A1 (en) 1999-02-11
WO1999006050A1 (fr) 1999-02-11
ATE262337T1 (de) 2004-04-15
ID24566A (id) 2000-07-27
EP0998930A1 (en) 2000-05-10
TR200000263T2 (tr) 2000-09-21
NO20000469L (no) 2000-03-28
HK1027290A1 (en) 2001-01-12
NZ502537A (en) 2002-11-26
DE69822636D1 (de) 2004-04-29
RU2193887C2 (ru) 2002-12-10
US6380179B1 (en) 2002-04-30
PL338414A1 (en) 2000-11-06

Similar Documents

Publication Publication Date Title
ATE384524T1 (de) Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis
DK0564350T3 (da) 3, 5-di-tert-butyl-4-hydroxyflavoner, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger med antioxidant- og anti-vasokonstriktorisk virkning
PT918776E (pt) Sintese total de acilfulvenos antitumorais
BG104569A (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds
PT998930E (pt) Composto azasteroide para o tratamento da alopecia hirsutismo ou seborreia
NO981393L (no) Guanidinoproteasehemmere
BR0014615A (pt) Derivado de ácido fosfÈnico que apresenta atividade inibidora contra carboxipeptidase b
AU681021B2 (en) Indole derivative and medicine containing the same
PT963998E (pt) Composicoes para tratar ou prevenir cancro prostatico
ES2064347T3 (es) Un proceso para la preparacion de un derivado de cinamoilamida.
ATE206699T1 (de) Uch-15-verbindungen